Literature DB >> 12730050

Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects.

Nikolaj Ihlemann1, Christian Rask-Madsen, Anders Perner, Helena Dominguez, Thomas Hermann, Lars Køber, Christian Torp-Pedersen.   

Abstract

An oral glucose challenge causes transient impairment of endothelial function, probably because of increased oxidative stress. During oxidative stress, endothelial nitric oxide (NO) synthase (eNOS) becomes uncoupled because of decreased bioavailability of tetrahydrobiopterin (BH4), an essential cofactor of eNOS. Therefore, we examined whether an acute supplement of BH4 could restore endothelial dysfunction induced by an oral glucose challenge. Healthy subjects were examined in 53 experiments. Forearm blood flow was measured by venous occlusion plethysmography. Dose-response studies were obtained during intra-arterial infusion of serotonin to elicit endothelium-dependent, NO-specific vasodilation and during sodium nitroprusside (SNP) infusion to elicit endothelium-independent vasodilation. Subjects were examined before (fasting) and 1 and 2 h after an oral glucose challenge (75 g) with serotonin (n = 10) and SNP (n = 8). On different days (6R)-5,6,7,8-tetrahydro-l-biopterin dihydrochloride (6R-BH4; n = 10), the active cofactor of eNOS or its stereoisomer (6S)-5,6,7,8-tetrahydro-l-biopterin sulfate (6S-BH4; n = 10), which is inactive as a cofactor, was added 10 min (500 microg/min) before and during the 1-h postchallenge serotonin dose-response study. In vitro studies showed that 6R-BH4 and 6S-BH4 were equipotent antioxidants. Serotonin response was reduced by 24 +/- 7% (at the highest dose) at 1 h postchallenge compared with fasting (P = 0.001) and was restored 2 h postchallenge. The reduction was reversed by the administration of 6R-BH4 but not by 6S-BH4. SNP responses were slightly increased 1 and 2 h postchallenge (increased by 15 +/- 13% at third dose 2 h postchallenge, P = 0.0001). An oral glucose challenge causes transient, NO-specific, endothelial dysfunction, which may be reversed by BH4. Transient postprandial endothelial dysfunction may be partly explained by reduced bioavailability of BH4 and NO.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730050     DOI: 10.1152/ajpheart.00008.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  36 in total

Review 1.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

Review 2.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

3.  Acute effects of hyperglycaemia with and without exercise on endothelial function in healthy young men.

Authors:  Weili Zhu; Chongfa Zhong; Yingjie Yu; Keji Li
Journal:  Eur J Appl Physiol       Date:  2007-01-06       Impact factor: 3.078

4.  Time-course changes of nLDL-induced erectile dysfunction.

Authors:  N Durmus; A Toylu; S Evcim; B C Soner; O Demir; E Kahraman; T Demir; B Irer; S Gidener; N Atabey; A Esen
Journal:  Int J Impot Res       Date:  2017-03-16       Impact factor: 2.896

5.  Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II.

Authors:  Sabine Kossmann; Hanhan Hu; Sebastian Steven; Tanja Schönfelder; Daniela Fraccarollo; Yuliya Mikhed; Melanie Brähler; Maike Knorr; Moritz Brandt; Susanne H Karbach; Christian Becker; Matthias Oelze; Johann Bauersachs; Julian Widder; Thomas Münzel; Andreas Daiber; Philip Wenzel
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

Review 6.  Postprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions.

Authors:  Miriam Jacome-Sosa; Elizabeth J Parks; Richard S Bruno; Esra Tasali; Gary F Lewis; Barbara O Schneeman; Tia M Rains
Journal:  Adv Nutr       Date:  2016-03-15       Impact factor: 8.701

Review 7.  Small molecules as therapeutic agents for inborn errors of metabolism.

Authors:  Leslie Matalonga; Laura Gort; Antonia Ribes
Journal:  J Inherit Metab Dis       Date:  2016-12-13       Impact factor: 4.982

8.  5-Methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium-dependent vascular relaxation.

Authors:  Tudor M Griffith; Andrew T Chaytor; Linda M Bakker; David H Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

Review 9.  Mechanisms for early microvascular injury in obesity and type II diabetes.

Authors:  H Glenn Bohlen
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

Review 10.  Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects.

Authors:  Zvonimir S Katusic; Livius V d'Uscio; Karl A Nath
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.